July 28th, 2014
No Reduction in Atherosclerosis Progression With Menopausal Hormone Therapy
Larry Husten, PHD
More than a decade ago the Women’s Health Study produced surprising and important results when it showed that broad use of hormone replacement therapy did not reduce cardiovascular risk in postmenopausal women. However, the study also led to speculation that hormone therapy might be beneficial when delivered closer to the time of menopause. Now a study published […]
January 13th, 2014
Selections from Richard Lehman’s Literature Review: January 13th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the risk for MI and ischemic heart disease among overweight and obese people with and without metabolic syndrome, and the lower risk for CV events in postmenopausal women taking estradiol compared with conjugated equine estrogens.
October 1st, 2013
Long-Term Study Results Offer Broad Perspective on Hormone Therapy for Menopausal Women
Larry Husten, PHD
More than a decade ago, the NHLBI’s Women’s Health Initiative trials overturned the conventional wisdom that hormone therapy (HT) for menopausal women helped protect women from a broad spectrum of chronic diseases, including cardiovascular disease. The findings caused dramatic reductions in the use of HT but important questions remained, many involving the age or time since menopause […]
NEJM Journal Watch — Recent Cardiology Articles- More Data on Finerenone for Heart Failure with Preserved or Mildly Reduced Ejection Fraction
- Cardiovascular Outcomes of Tirzepatide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long Is Long Enough?